Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | +1.26% | -12.50% | -32.64% |
May. 15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
May. 09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.64% | 65.9M | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- Rallybio Says Data From Phase 1 Trial of RLYB212 Support Once-Per-Month Dosing Regimen in Planned Phase 2 Study